Pritchard and colleagues suggest that type IV collagen genes, including COL4A1 and COL4A2 may be over-expressed, and COL3A1 and COL5A2 expression may be repressed by androgen exposure [53], suggesting an alternative pathway by which androgen activity may influence BPH progression. This evidence concerns the gene COL3A1 and benign prostatic hyperplasia.